catalyst

Study Of An FDA-approved Drug As Additional Therapy In Patients With Schizophren — primary completion

as of 2026-07-01
at a glance
2005-07 · ActualThis event happened.
Synthesized from structured facts only — each point cited above.

Event

What
Study Of An FDA-approved Drug As Additional Therapy In Patients With Schizophren — primary completion
Type
Trial Readout
Date
2005-07
Date type
ACTUAL
Phase
Phase 3
This event happened.